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Abstract: Background
To improve the lives of patients in primary care requires the involvement of service
users in primary care research. We aimed to explore the extent, quality and impact of
patient and public involvement (PPI) in primary care research.
Methods
We extracted information about PPI from grant applications, reports and an electronic
survey of researchers of studies funded by the NIHR School for Primary Care
Research (SPCR). We applied recognised quality indicators to assess the quality of
PPI and assessed its impact on research.
Results
We examined 200 grant applications and reports of 181 projects. PPI was evident in
the development of 47 (24%) grant applications. 113 (57%) grant applications included
plans for PPI during the study, mostly in study design, oversight, and dissemination.
PPI during projects was reported for 83 (46%) projects, including designing study
materials and managing the research. We identified inconsistencies between planned
and reported PPI. PPI varied by study design, health condition and study population.
Of 46 (24%) of 191 questionnaires completed, 15 reported PPI activity. Several
projects showed best practice according to guidelines, in terms of having a PPI budget,
supporting PPI contributors, and PPI informing recruitment issues. However few
projects offered PPI contributors training, used PPI to develop information for
participants about study progress, and had PPI in advising on dissemination.
Beneficial impacts of PPI in designing studies and writing participant information was
frequently reported. Less impact was reported on developing funding applications,
managing or carrying out the research. The main cost of PPI for researchers was their
time. Many researchers found it difficult to provide information about PPI activities.
Our findings informed:
*a new Cost and Consequences Framework for PPI in primary care research
highlighting financial and non-financial costs, plus the benefits and harms of PPI
*15 co-produced recommendations to improve PPI in research and within the SPCR.
Conclusions
The extent, quality and impact of PPI in primary care research is inconsistent across
research design and topics. Pockets of good practice were identified making a positive
impact on research. The new Cost and Consequences Framework may help others
assess the impact of PPI.
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Response to Reviewers: 25th March 2018
Dear Editor-in-Chief,
MS:  RIAE-D-17-00050
The extent, quality and impact of patient and public involvement in primary care
research: a mixed methods study
Response to reviewers’ comments
On behalf of the authors, please pass on our gratitude to the reviewers for their fair and
constructive critiques of our manuscript.
We have responded to each one of the reviewers’ points below and revised the
manuscript accordingly. The revisions have been highlighted in red text.
We hope that we have addressed the reviewers’ concerns satisfactorily and improved
the manuscript.
We look forward to hearing from you.
Kind regards
Steven Blackburn, PhD
Research Institute for Primary Care Health Science, Keele University
 
#
Reviewers Comment
Response
1.
#1: The article discussion section is the clearest account of the study's interest to the
reader and I wondered if some of that language could be brought to the front of the
paper. I was anxious to reach the commentary as to the co-produced
recommendations to improve PPI in primary care research. There is no account of
what those are in the plain English summary for example.
Thank you for this kind comment. For the plain English summary, we have now
included on how we used recognised quality indicators to ass the quality of PPI in
studies and its impact.
We have also include a general description of the types of recommendations that were
co-produced. Unfortunately, a more detailed account of all 15 recommendations is
difficult to achieve within the 350 word limit for this section
2.
#1: The importance of the study is in the materials it has used to conduct the scrutiny
and the recommendations it has developed from these materials and their responses.
Thank you
3.
#1: Interestingly, there was no exposure of the study's own PPI 'costs and
consequences' quality assurance score. The article does not tell us about, for example,
remuneration of the involved public contributors. An additional table could well bring
the article to some more lively consideration if it disclosed its own self -scored costs
and consequences matrix?
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This is a great suggestion. We have added our own self-assessment score against the
quality indicators, and identified provided a cost and consequences framework for this
study (supplementary file). We have summarised these on pages 21-22, line 592-607.
4.
#1:The article's written presentation - no doubt tied to editorial convention - could
nonetheless be more enthusiastic I suggest in its opening sections. There was a sense
of over-formalised writing - until the discussion section
We have followed reporting convention. However, we have reviewed the writing style in
the opening sections and revised as appropriate.
5.
#1: Although the GRIPP2 checklist was mentioned, along with INVOLVE's new
standards, it is not within the compass of this review to comment on the usefulness or
connectedness of this study's costs and consequences matrix to other PPI quality
assurance approaches. It would be good, nonetheless to see those brought together
into a single or shared document.
Thank you for making this point. At the time of writing, we did bring together existing
frameworks and resources (e.g. Going the Extra Mile recommendations, INVOLVE
Values and Principles Framework, and SCPR PPI Strategy) as we were formulating
our recommendations, in light of the costs and consequences identified during the
study (p.18, lines 466-470).  We also highlighted that it’s too early to see the effect of
recent development like the National Standards and the GRIPP2 on PPI quality.
However, we have now added commentary on how future studies should consider how
the National Standards for Public Involvement and GRIPP2 reporting checklist
complement and facilitate each other (in the context of the costs and consequences of
PPI highlighted in this study), to drive forward improvements in this field (page 20, lines
525-30)
6.
#2: I did wonder if the cost and consequences framework could be made bold: 'Cost
and Consequence Framework' to show this is something new and by adding a
sentence in the abstract about this might be good for the reader, at the moment it lacks
confidence as a framework. In the body of the text you could add a line about how this
is to complement the INVOLVE Cost Calculator.
Thank you for this suggestion. We have highlighted the novelty and importance of the
Framework in the abstract, along with a short description of it. (line 58-9)
We have added a sentence to highlight how the Cost and Consequences Framework
should be considered when using INVOLVE’s Involvement Cost Calculator [30].  (page
20, Line 528-30)
7.
#2: The tables and figures are labelled incorrectly on the actual Table titles and Figure
titles throughout, which made it hard to see which figure or table reflected the content
being described, but with a bit of searching I was eventually able to find which table or
figure fitted where.
We have checked that the tables and figures are now all labelled correctly
8.
#2: I would have liked a few more lines in the Conclusion about The Cost and
Consequence Framework and in the body of the text.
We have now added some more text about the Cost and Consequences Framework in
the Abstract, the Plain English Summary and in the Discussion (see my response to
comment #5)
9.
#2: Although in most places the authors offer the number of applications to accompany
the percentage, I wondered if this could be adopted throughout, this would help the
reader to understand in the context of the 200 application, 'x' number had specified …
so and so.
We have now included the number as well as a percentage throughout the paper
10.
#2: Some acronyms are introduced and then not followed through, e.g. 'PI' on p14,
similarly 'FR' is in the list of abbreviations but then not in the text (unless I missed
this).Keyword: should 'Framework' be added?
Thank you for spotting this. We have now addressed the erroneous acronyms
11.
#2: Sometimes n= is used to indicate number of applications, sometimes just the
number of applications, sometimes just a percentage is offered. For consistency, it will
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help to standardise this. On the following pages percentages offered without the
specific number of applications was noted: pages: 2, 12 (line 309),
We have now reported frequencies and percentages consistently throughout the
article.
12.
#2: I was unclear whether this work received specific funding? This needs clarity under
either Setting on p7 or on Funding section on p22.
To clarify the funding of this study, the statement on p.25 has been changed to “This
paper presents independent research funded by the National Institute for Health
Research School for Primary Care Research (NIHR SPCR).”  We have also included a
disclaimer about the views expressed in the paper.
13.
#2:  Tables and figures are all labelled incorrectly, e.g. there are five figure 1s at the
back. Table 3 is currently table 1 etc. These figures and tables are listed on pages:
7,10,12,13,14,15,16,17,21
We have addressed the labelling of the figures and tables throughout the article.
14.
#2: On p9 researcher 'SS' is listed, this person is not listed in the team information
Thank you for spotting this error. We have now changed it to the correct initials of the
author who conducted this piece of the study.
15.
#2: P10 what was the rationale for not doing PPI on the 26 projects? Was it the same
as the rationale provided on page 11? If so this needs explaining clearer.
Reasons provided for not reporting PPI were similar across completed and
uncompleted projects. We have inserted a new paragraph (p.11, line 270-275) to
describe this and provided some example rationales.
16.
#2: P11 what was the average length of projects?
This proposed duration of projects was not extracted in the analyses of grant
applications, and at the time of analysis, the start and finish dates of projects was not
available in the project documentation. Most research studies take approximately 2 to
3 years. However, it is likely that some of the SPCR studies may have been shorter,
and other studies may have taken longer to complete due delays, for example in
project set up or participant recruitment.  However without this data, it would be difficult
for us to calculate or comment on the duration of studies.
17.
#2: P13 on line 336, was there a justification offered as to why 20 projects did more
PPI than planned?
Information on the discrepancies between planned and reported PPI activities was not
available in the project documentation. We have provided opinions to why the
discrepancies may have occurred (page 14, lines 354-362)
18.
#2: P14 line 371 is there any literature to show this finding (of homogeneity in PPI)
being congruent with literature. Similar point about literature and finding congruence
about PPI being less common in methodological design and Systematic review (page
12)
The negative impact of PPI reported by one of the Principal Investigators was related
to the homogeneity of the young people recruited into the study, not the PPI
contributors. On page 15, line 395 we have clarified this sentence by stating that,
“young PPI contributors encouraged their friends to participate in a study on
reproductive health in young people.” We are not aware of any literature that reports
similar findings.
In terms of the comment about PPI being less common in methodological design and
systematic reviews, we have stated that our finding that PPI is more common in study
design such as clinical trials and mixed methods was also reported by Mathie et al
(2014) and Gamble et al (2014) (page 21, line 546). We had added that Mathie et al
also found that PPI was less common in observational and cohort studies (page 21,
547)
19.
#2: P17, can you offer a brief description about how your team understood 'co-
production' this is a contested term at the moment so clarity will help readers your
starting point.
We have revised section 6 [p18] which describes how the recommendations were co-
produced, giving additional detail to how researchers and PPI contributors worked
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together to develop and agree on the study’s recommendations
20.
#2: P18 line 468-469 text is larger than the rest of the document.
Thank you for spotting this. We have corrected.
21.
#2: In the discussion could you add a sentence about the 'Framework for public
involvement at the design stage of NHS, Health and Social Care research' when you
discuss some guidelines and frameworks?
We have now included a reference to this recently published framework (page 18, line
489-90).
22.
#2: Where you discuss the quality being indicators of good practice could you bring the
point back that people spent on average 0-30 hours on PPI (those with fewer hours are
less likely to have meaningfully engaged the public)
Thank you for making this insightful point. As suggested we have caveated our
statement that no specific example of poor practice were found with:
a) the finding that time spent on PPI was variable and, b) the suggestion that those
who spent fewer or minimal hours on PPI may not have spent sufficient time have
meaningfully engaged with the public (page 19, line 517-519)
23.
#2: P20 line 519 does bureaucracy reflect in the literature for PPI processes?
We have revised this paragraph to state reasons for researchers difficulty to provide
information on PPI and inability to pass on the PPI contributor survey are unclear and
not explained in the literature elsewhere (page 20, line 535-541)
24.
#2: Numbering error page 20. Number 3 featured twice in the list (line 520 and 525)
This has been corrected
25.
#2: Future impact of this study, p21. Can you add some more to about the cost and
consequence aspect.
We have included a sentence about the potential of the new Cost and Consequences
Framework to help other consider the wider impacts of PPI (page 23, line 624-626)
26.
#2: Table 3 under 'Other' Category the 'f' label description is later referred to as '$' in
notes form
Thank you. We have now corrected this error
27.
#3: I wondered if you might consider balancing a quote "Young people can be
unreliable - it's sometimes difficult to know whether they will turn up or not, and to plan
accordingly." which seems to generalise the behaviour of all young people, with some
discussion of how attendance at PPI groups can vary for all age groups, depending on
health conditions and other commitments
To address your valid comment, we have added the following sentence, “While the
respondent in the above quote has commented on young people, it should be noted,
however, that this is not generalizable of all young PPI contributors. The participation of
all PPI contributors can be impacted by many factors, such as availability on scheduled
meeting dates, changes in health status and other commitments.” (page 16, line 419-
422)
28.
#3: I also wondered if there had been any discussion as to whether provision of admin
support, or lack of it, had contributed to the cases where there was no record of costs
and benefits of PPI activity.  If so, perhaps this could be included in the article.
While we could not identify specific reasons for poor record keeping for PPI, other than
simple statements from respondent that it was “due to a lack of information”, we have
included the possibility of insufficient administrative supports as a reason (page 20,
lines 535-541)
29.
#3: Line 41: Is the 47 (24%) of projects out of the 181 reports?  If so, for consistency,
should a number be given for where there was PPI from the 200 of grant applications?
Not just 57% - but give a precise number too?
We have clarified the denominator and included the count of grant applications or
projects as well as the percentages (page 2, line 43)
30.
#3: Line 42: delete semi-colon after study  ... during the study; mostly in study oversight
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This has been deleted.
31.
#3: Line 43: delete extra f in Ffrequent activities  (This typo does not occur on the
opening page abstract - only on the internal abstract
This spelling mistake has been corrected
32.
#3: Line 44: State how many projects in numbers?
We have included the count of grant applications or projects as well as the
percentages (page 2, line 44)
33.
#3: Line 52: Suggest delete PPI activities which was more common.  Suggest insert:
and the PPI activities which were more common were..
We have revised this sentence to: PPI during projects was reported for 83 (46%)
projects, including designing study materials, advising on methods, and managing the
research (page 2, line 44-45)
34.
#3: Line 52: Suggest sentence reads:  Beneficial impacts of PPI and the PPI activities
which were more common were frequently reported in designing studies and writing
participant information
To simplify the sentence, we have deleted end of the sentence (“PPI activities which
was more common”) to leave: “Beneficial impacts of PPI was frequently reported in
designing studies and writing participant information.” (page 2, line 52)
35.
#3: Line 55: suggest deleting semi-colon ; and rewording ... suggesting record-keeping
was poor. SUGGESTION:  to insert mention of the workshop somewhere in this
section.
As we have included additional text into the abstract and plain English summary, we
have simplified the sentence by removing our suggestion as to why researchers found
it difficult to provide information about PPI activities
36.
#3: Page 3
Keywords:
Line 66:   suggest inserting Framework
Thank you. We have included ‘framework’ in the keywords (page 3, line 68)
37.
#3: Page 4
Plain English Summary
Line 69 NOT ENTIRELY CLEAR.  Suggest deleting...who receive primary care
services in the research process.  ? insert instead... insights and experiences of
patients of the research process which they receive in primary care.    (If that's what
you mean?)
We have revised this sentence to read: “Therefore it is important for research into
primary care to be informed by the insights and experiences of patients who receive
these services.” (page 3. Lines 72-72)
38.
#3: Line 75 NOT ENTIRELY CLEAR.   "did not have PPI as they planned to initially."
Does this mean that the PPI got abandoned, or does this mean that the form of PPI
input changed as it was going along?  Sort of 'Let's not do that...'  'Instead, let's do ...'
Could do with clarification
We have revised the sentence to highlight the important finding that “some studies did
not undertake the PPI activities initially planned and funded for” (page 3, lines 77-8)
39.
#3: Line 77:  I wondered if inserting the word 'not' would help emphasise the lack of
training offered.... such as not offering PPI contributors training
Thank you for this suggestion, but we were highlighting that these good practice were
not followed. Inserting ‘not’ might suggest that ‘not offering PPI contributors training’
was good practice. Nevertheless we have revised this sentence to emphasise that few
studies offered these good practices. (page 4, lines 80-1)
40.
#3 Line 78 .. Not... using PPI to develop information... and ... not ... having PPI to
advise on publishing findings
As above
41.
#3 Line 81  NEEDS EXPLANATION: I suggest that you explain what Higher Quality
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means in practical terms.  It seems obvious that higher quality will have most impact.
However lay readers may not all understand what goes into making the approach of
'higher quality'.  Even talking about 'a higher number of quality indicators met for a
single project' (as on page 9, line 207) is not that easily understandable to lay people
We have revised this sentence to clarify the issue on quality. It now: ‘Most impact was
reported when the approach to PPI included more indicators of good practice.’ (page 4,
lines 83-4)
We have also made a similar change to the sentence on page 9, line 212-3
42.
#3 Line 82:  delete suggesting and insert this suggested that...  so the sentence will
read  Many researchers found it difficult to provide information about PPI activities;  this
suggested that record-keeping was poor
As we have included additional text into the abstract and plain English summary, we
have simplified the sentence by removing our suggestion as to why researchers found
it difficult to provide information about PPI activities (page 4, line 84-5)
43.
#3: Page 5
Background:
Line 97: ...[5,6].   Delete i and insert capital I so that it reads Its positive impacts are...
Thank you for spotting the error. We have now corrected this.
44.
#3: Line 111:  insert comma after limited
Thank you for spotting the error. We have now corrected this.
45.
#3: Line 116: Delete ninety percent and insert 90%
We have now changed this to 90% (page 5, line 119)
46.
#3: Line 117: NOT ENTIRELY CLEAR  Suggest the sentence is amended to read:
Therefore it is important to gather the views, insights and experiences of patients about
the research process which they receive in primary care.   (If that's what you meant)
As per previous comment, we have revised this sentence to read: “Therefore it is
important for research into primary care to be informed by the insights and
perspectives of patients who receive these services.” (page 6, line 120-121)
47.
#3: Line 120:  insert are   after [20-22
We have now added this
48.
#3: Line 121:  insert which have so that it reads ....description of the PPI activities
which have taken place
We have now added this.
49.
#3: Line 129:  No 3 EDITORIAL QUERY:  Should patients (having the health research
done on them) be referred to here in this article?
The impact of PPI on the patients having health research done on them (study
participants) was not in the scope of the aims of this project. Nevertheless this is an
interesting research question on its own
50.
#3 Line 137: Does the lack of ability need specifying?  maybe ... lack of records... lack
of staff to look this up?  ... or whatever
We have now clarified this sentence by stating that a cost and consequences analysis
was chosen due to the lack of available data and recorded information about PPI (page
6, line 141-2)
51.
#3 Line 143: Would it be useful to say how may PPI contributors attended the
workshop?  I was wondering as I was reading.
We have clarified that eleven PPI contributors were involved in the workshop (page 6,
line 148)
52.
#3 Page 8
Researcher and PPI contributor surveys:
Line 199:   Delete er  from sentence beginning To examine the quality of PPI in primary
care researchER  so that it reads ... in primary care research.
Thank you for spotting this. We have now corrected it.
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53.
#3 Page 10
Results:
Researcher and PPI contributor survey
1.2 PPI during the projects
Line 252: delete s from ... (plus one projects whose...)
Thank you for spotting this. We have now corrected it
54.
#3 Page 12
1.8
Line 299 I think it should be:  delete were  insert was so that it reads ...Though the
study population of two-thirds of SPCR funded projects was patients only...
Thank you for spotting this. We have now corrected it
55.
#3 Page 13
1.9 The type of PPI
Line 333   ? Font size?  Figure 3 looks inconsistent in size
Thank you for spotting this. We have now corrected it
56.
#3: Page 14
3. The impact of PPI from the researchers' perspective
Line 371:  NOT ENTIRELY CLEAR about this sentence.  Did the authors mean that
'The only negative impact reported was the view that a more homogenous (rather than
diverse) study ended up being recruited, since PPI contributors encouraged their own
friends to participate.   ???
We have clarified this sentence by stating that, “young PPI contributors encouraged
their friends to participate in a study on reproductive health in young people.” (page 15,
line 395-6)
57.
#3 p15
3.1 Quality-Impact Index scores
Line 399: insert in  so that it reads ... activities in which the PI reported a perceived
impact)...
This has now been added
58.
#3 Page 16
4. The financial costs of PPI
Line 410: insert a space before and after -
We have removed the ‘-‘ (page 17, line 438)
59.
#3 Line 414:  QUERY  Would it be relevant to make some reference here about help
with transport (not costs, but booking, on behalf of PPI participants, taxis to make it
possible for them to attend if they had a condition which made it difficult to access
public transport)??
We have provided examples of the travel costs that might have been reimbursed: e.g.
car mileage, public transport, parking page 17, (line 442)
60.
#3 Line 424:  delete as  so that it reads:  Table 4 presents a framework ..
We have removed ‘as‘ (page 17, line 453)
61.
#3 Page 18
Discussion
Line 466:  insert ly so that it reads  frequently
We have inserted ‘ly’ to frequent (page 18, line 500)
62.
#3 Line 467 EDITORIAL QUERY  Line 505 says that the most commonly stated PPI
activity was ... reviewing patient information leaflets ... Do not 'Reviewing' and
'Developing' go hand in hand?  Maybe it would be worth addressing that point.  On
Line 467 it says 'less frequently for other aspects of the research process (eg
developing Participation Information Leaflets)
This statement relates to a finding from Gamble et al’s publication, which simply
referred to PPI in reviewing patient information. We have not made any assumptions or
interpretations with this. PPI may have helped to develop patient information, or simply
reviewed documents produced by the researchers. In our study we specifically asked if
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PPI was involved in ‘developing’ participant information.
63.
#3 Line 468: instert t    conducting the research
We have now correcting this spelling error (line 502)
64.
#3 Line 468: some of the font size looks inconsistent  - ? too large
We have checked that all font sizes are consistent
65.
#3 Line 470: query whether re-wording would help - maybe something like:  ... with PPI
semingly less prevalent in study designs where there was less direct contact with the
study patient/participants
Thank you for this suggestion. We have reworded the sentence. (line 504)
66.
#3 Line 472:  Is some of the font size on this line too large?
We have checked that all font sizes are consistent
67.
#3 Line 481: insert  s   terms
We have corrected this (line 515)
68.
#3 Line 483:  Typo:   should be Boote et   (not Boote at)
We have corrected this (line 520)
69.
#3 Line 483:  some of this line is in a different size font
We have checked that all font sizes are consistent
70.
#3 Page 19
Line 505: - is this at odds with line 467?
See our response to comment #62
71.
#3 Page 21
Future Impact of the Study
Line 557: IMPORTANT
IS THIS REFERENCE THE WRONG NUMBER?  No. 30 seems to be Boote, so what
should the correct number here be for NIHR School for Primary Care Research...?
Thank you for highlighting this. We have now amended the reference. (line 598)
72.
#3 Line 565: To make it clearer to read, would it be possible to have the bracketed
numbers on separate lines:
... in terms of:
1) establishing..
2) recording and reporting...
3) promoting and..
Then a new paragraph for
This Study did identify...
We have now put this into a numbered list, on separate lines (lines 633-636)
73.
#3 Line 567: If you don't do separate lines as suggested above, then need to insert a
comma after PPI,
We agree that a numbered list, on separate lines is clearer
74.
#3 Page 22
Line: 591 ? Amend sentence to that it reads:  The work presented in this paper was
independent research commissioned by...
We have now checked that we have the correct wording of the funding
acknowledgement for the SPCR (line 661)
75.
#3 Page 23
Line 596: Important:   Insert the word Health so that it reads:  Collaborations for
Leadership in Applied Health Research and Care West Midlands
We have now corrected this (line 665)
76.
#3 Line 610: Insert k so that it reads thank
We have now corrected this (line 680)
77.
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#3 Line 614:  Does superscript no. 1 need to be deleted, or where does it refer to?  I
couldn't find out what it referred to.
We use the endnote to define ‘PPI contributors’ on page 5 (line 110)
78.
#3 Page 24
Line: 624: Some punctuation needed in title of Going the Extra Mile.  Suggest it reads:
Going the Extra Mile - a strategic review ...
We have corrected the reference as suggested (line 694)
79.
#3 Line 640:  Is some of the font size in this line too large?  longitudinal study  ???
We have checked that all font sizes are consistent
80.
#3 Page 25:
Line 649:  insert apostrophe after researchers  so that it reads  researchers' attitude
We have corrected the reference as suggested (line 699)
81.
#3 Page 26
Line 672: insert a space before dash and after dash ... research - an example...
We have corrected the reference as suggested (line 739)
82.
#3 Page 30 - 34
IMPORTANT
What is the correct Table number?  Is it meant to be Table 3 ??
Another question:  would it help the reader to stay looking on the correct line if the table
where in some sort of a grid?
We have checked the numbering of the tables and corrected accordingly
Thank you for this comment. We have checked the author guidelines on tables and
have used the conventional format of tables for journal publications. Therefore, we
have not reformatted the table as suggested
83.
#3 Page 36 Line 706 Table 4
EDITORIAL
Would it be easier for the reader if the internal boxes were re-formatted?  There is a lot
of indentation going on which makes it distracting for the reader.
Thank you for this comment. We have removed the unnecessary indentation.
84.
#3 Page 37 Individual page Line 21
Conducting and managing
EDITORIAL QUERY/EXPLANATION?
It would be informative to give the age range of the young.
Would it be possible to give, either here or somewhere in the article, an idea of the
facilitation process (if any) specifically designed to engage young people?
Dissemination
It was not always possible to determine the ages or age range of children and young
adults from the study documentation. Sometimes, ages were provided, sometimes the
documentation simply referred to children. So we have assumed children and young
adults to be 17 and under.
We have included this age range (0 – 17 years) for the children and young adults
category in the table and added an explanation in the table footnotes (‘g’) (Line 774).
85.
EXPLANATION requested: Why is PPI contributors attending conferences and external
events considered to be a Minus?
Thank you for this comment and appreciate that the statement could be interpreted in
this way. We were referring to the financial costs of PPI contributors attending
conferences and external events. We revised the statement to make this clearer. (table
4, page 38)
86.
#3 Page 39 Footnote
EDITORIAL QUERY Sorry, but this Footnote says Sometimes included within the
direct payment.  But what is it which is sometimes included within the direct payment.
The previous reference says:  Direct payment of PPI contributors for attending
meetings
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Is there another aspect which is sometimes included within direct payments which
needs a link to this number?  Or should this footnote be deleted?
The footnote number was linked to the wrong statement. It should be linked to the
travel costs of PPI contributors attending meetings (in the row below) – as
reimbursement of travel expenses is sometimes included in the direct payment made
to PPI contributors.
87.
#3 Page 40 Table 5
Individual page line no. 45:  Delete ing  All the other items say 'Improve'  'Stimulate'
'Create' (not improving...)
We have revised this for recommendation number 8.
88.
#3 page 41
Individual page line no. 27:  Insert full stop after B
We have included the full stop (bottom of page 41)
89.
#3 Page 42
Line 716  Should this be Table 6
We have checked the numbering of the tables and corrected accordingly
90.
#3 Line 717
Individual Page Line no. 7:  Does there need to be a reference to Primary Care
somewhere here
Individual Page Line No. 7:  Typo:  delete second o  so that it reads very aware of the
varied approaches to PPI being undertaken ...
To clarify the types of research projects, we have included the reference so it now
reads: As a lay coordinator of a growing group of research users involved in a variety
of primary care research projects across a clinical trials unit… (line 789)
91.
Line 717
Individual Page Line No. 7:  Typo:  delete second o  so that it reads very aware of the
varied approaches to PPI being undertaken
We have corrected the spelling mistake in the quote (p 43, line 7)
92.
#3 Individual Page Line No. 20:  Insert apostrophe after patients'  patients' daily care..
We have corrected this
93.
#3 Individual Page Line no. 22:  I believe it should be spelt practice with a c in this case
We have corrected this
94.
#3 IMPORTANT
Correct numbers for the Figures need to be typed onto the tops of the relevant tables.
At the moment they all say Figure 1 apart from on the Download button
We have checked the numbering of the tables and corrected accordingly. I think this is
an error with how the Figures are labelled during the uploading process
95.
#3 VERY IMPORTANT! within Figure No. 4
The fourth from the top quality indicator very much needs an l inserted so that it will
read Public
Last line within the table:  delete c  and insert s to that it reads:  Public involvement
advised on informing..
Yes, very important. Thank you for spotting this. We have now corrected.
We have corrected this
96.
#3 Figure No. 5
? EDITORIAL
Association between the Quality Score (number of quality indicators met by a project)
Do we need a link to the Quality Score/Impact Score to see what the activities were
Also:  Typo in heading:  insert in so that it reads .. (number of PPI activities in which the
PI reported a perceived impact)
Thank you for this comment.
Powered by Editorial Manager® and ProduXion Manager® from Aries Systems Corporation
We have not linked impacts of PPI with the individual Quality Indicators met in the
Quality-Impact Index Score. In the 13 projects included in this analysis, the researchers
perceived impact on different types of PPI activities, so it would be difficult to separate
these activities out to provide anything meaningful. We have discussed in the main text
that the most impact was perceived on the PPI activities most commonly conducted
(shown in Figure 2). In Figure 5, we have summed the number of PPI activities in
which the Principal Investigators perceived an impact.
We have inserted the word ‘in’ in the heading
97.
#3 SUPPLEMENTARY MATERIAL
- If possible, on Patient Survey of the Costs and Effects of Patient and Public
Involvement (PPI) in Primary Care Research,
P6. No 9. amend Typo:  Delete ing and insert e so that it will say:  Leave lines blank
where you did not receive any help.
We have corrected this simple spelling mistake
98.
#3  Patient and Public Involvement in your research project questionnaire:
For publication, would it be possible to align the questions which are most obviously
semi-indented, to aid the reader?
A9, A11, A12, A18;  B3, B6, B9, B10
We are not sure about what the reviewer is asking to change. The style and format of
the questionnaire was developed and agreed with our PPI group (as well as being
ethically approved) so we would prefer not to change them.
99.
Reviewer #4: This is a model of how to write a clear, compelling article with a defined
outcome. It shows the value of ppi ; it outlines the issues which cause concern; it
identifies the weaknesses in the research it is doing; it offers ideas for future research.
Thank you for this kind comment. The authors are greatly appreciative.
Additional Information:
Question Response
Powered by Editorial Manager® and ProduXion Manager® from Aries Systems Corporation
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ABSTRACT 30 
Background 31 
To improve the lives of patients in primary care requires the involvement of service users in primary care 32 
research. We aimed to explore the extent, quality and impact of patient and public involvement (PPI) in 33 
primary care research.  34 
 35 
Methods 36 
We extracted information about PPI from grant applications, reports and an electronic survey of researchers of 37 
studies funded by the NIHR School for Primary Care Research (SPCR). We applied recognised quality indicators 38 
to assess the quality of PPI and assessed its impact on research. 39 
 40 
Results 41 
We examined 200 grant applications and reports of 181 projects. PPI was evident in the development of 47 42 
(24%) grant applications. 113 (57%) grant applications included plans for PPI during the study, mostly in study 43 
design, oversight, and dissemination. PPI during projects was reported for 83 (46%) projects, including 44 
designing study materials and managing the research. We identified inconsistencies between planned and 45 
reported PPI. PPI varied by study design, health condition and study population.   46 
Of 46 (24%) of 191 questionnaires completed, 15 reported PPI activity. Several projects showed best 47 
practice according to guidelines, in terms of having a PPI budget, supporting PPI contributors, and PPI 48 
informing recruitment issues. However few projects offered PPI contributors training, used PPI to develop 49 
information for participants about study progress, and had PPI in advising on dissemination.   50 
 51 
Beneficial impacts of PPI in designing studies and writing participant information was frequently reported. Less 52 
impact was reported on developing funding applications, managing or carrying out the research. The main cost 53 
of PPI for researchers was their time. Many researchers found it difficult to provide information about PPI 54 
activities.  55 
 56 
Our findings informed: 57 
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 a new Cost and Consequences Framework for PPI in primary care research highlighting financial and 58 
non-financial costs, plus the benefits and harms of PPI 59 
 15 co-produced recommendations to improve PPI in research and within the SPCR.  60 
 61 
Conclusions 62 
The extent, quality and impact of PPI in primary care research is inconsistent across research design and topics. 63 
Pockets of good practice were identified making a positive impact on research. The new Cost and 64 
Consequences Framework may help others assess the impact of PPI.   65 
 66 
Keywords 67 
Patient and public involvement; quality; impact; mixed methods, primary care research; Cost and 68 
Consequences Framework  69 
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Plain English Summary 71 
In the UK, more patients go to primary care than other parts of the health service. Therefore it is important for 72 
research into primary care to include the insights and views of people who receive these services.  To explore 73 
the extent, quality and impact of patient and public involvement (PPI) in primary care research, we examined 74 
documents of 200 projects and surveyed 191 researchers. 75 
We found that about half of studies included PPI to develop research ideas and during the study itself. 76 
Common activities included designing study materials, advising on methods, and managing the research. Some 77 
studies did not undertake the PPI activities initially planned and funded for. PPI varied by study design, health 78 
condition and study population.  We found pockets of good practice: having a PPI budget, supporting PPI 79 
contributors, and PPI informing recruitment issues. However, good practice was lacking in other areas. Few 80 
projects offered PPI contributors training, used PPI to develop information for participants about study 81 
progress and included PPI to advise on publishing findings.   82 
Researchers reported beneficial impacts of PPI. Most impact was reported when the approach to PPI included 83 
more indicators of good practice. The main cost of PPI for researchers was their time. Many reported 84 
difficulties providing information about PPI. 85 
In partnership with PPI contributors, we have used these findings to develop:   86 
 a new Cost and Consequences Framework for PPI highlighting financial and non-financial costs, 87 
benefits and harms of PPI 88 
 15 co-produced recommendations to improve the practice and delivery of PPI. 89 
 90 
 91 
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BACKGROUND 92 
Actively involving patients and the public in research is seen as a marker of good research practice because it 93 
leads to research that is relevant, better designed, with clearer outcomes, and a faster uptake of new evidence 94 
[1]. Now a requirement and priority of many research funding bodies, patient and public involvement (PPI) is 95 
promoted at all stages throughout the research cycle [2]. The recent National Institute for Health Research 96 
(NIHR) Going the Extra Mile report highlighted the need to improve the quality and practice of PPI in health 97 
and social care research [3]. In response to NIHR recommendations by the NIHR, INVOLVE has published their 98 
Values and principle’s Framework for best practice in PPI [4].  99 
PPI has been documented in a number of research areas [5, 6]. Positive impacts are reported for all 100 
stages of research, including enhancing its quality and appropriateness, an increased understanding and 101 
insight of researchers into their research field, and the increased sense of self-worth, confidence and skills 102 
gained by PPI contributorsi as a result of their involvement [7, 8]. PPI has also been associated with success in 103 
achieving participant recruitment targets in studies, securing funding, designing study protocols and choosing 104 
relevant outcomes [9, 10].  Recent research has identified the characteristics of effective PPI [11] and the 105 
mechanisms required to sustain it [12].   106 
In contrast, reported negative impacts are PPI contributors’ frustration with the lengthy process and 107 
lack of feedback, the extra time needed to complete research, time constraints of patients and researchers, 108 
and the increased financial costs [10].  Moreover, PPI can be tokenistic due to negative attitudes of 109 
researchers and the requirements of research funders [10, 13]. Variation in the context of, and approaches to, 110 
PPI, combined with lack of validated tools to assess its quality, causes challenges to identify best practice of PPI 111 
and its impact [10, 14]. 112 
 Though PPI in research is a clear priority for the government, the NIHR and other research 113 
organisations, there is growing, though limited, evidence relating to the costs (financial and non-financial) and 114 
consequences (benefits and harms) of PPI in research . This seems to be driven by the lack of and poor quality 115 
of reporting [7, 15, 16]. 116 
  Our study is set in the context of primary care research. That is, research conducted within health 117 
services providing first-contact care for patients (e.g. general practices, district nursing, and community-based 118 
health services) [17]. 90% of all NHS interactions occur in primary care [18], with the management of chronic 119 
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illnesses a key component. Therefore it is important for research into primary care to be informed by the 120 
insights and perspectives of patients who receive these services.  121 
However, little is known about the extent, quality and impact of PPI across the whole range of 122 
primary care research. To date, the small number of primary care studies reporting on PPI [19-21] are largely 123 
limited to a description of the PPI activities which have taken place. More recently, a case study of a primary 124 
care research centre reported how dedicated infrastructure and resourcing for PPI, flexible working practices, 125 
leadership, and secure funding has enabled the fostering of sustained long term PPI across all of its research 126 
[12, 22]. 127 
The literature in this area is limited and the benefits and costs of PPI for both researchers and the 128 
public is unclear. Our study therefore set out to gain a broader understanding of PPI in primary care research. 129 
Specific research questions were:  130 
1. What is the extent of PPI in primary care research? 131 
2. What is the quality of PPI in primary care research? 132 
3. What is the impact of involvement on PPI contributors, researchers and research institutions 133 
involved?  134 
4. What are the costs associated with PPI in health research? 135 
The four research questions were addressed through use of surveys, analysis of relevant research documents 136 
and a workshop.  Results from research questions three and four were analysed and structured as a cost-137 
consequence framework, a largely qualitative way of summarising key costs (financial costs as well as negative 138 
impacts on individuals or institutions) and key benefits (financial savings and positive impacts).  Cost-139 
consequence analysis is typically used by economists when it is not feasible to conduct a standard economic 140 
evaluation.  In this case, cost-consequence analysis was adopted due to a lack of available data and recording 141 
information about PPI to accurately quantify all monetary costs and the lack of an appropriate single metric for 142 
summarising non-monetary consequences. 143 
 144 
METHODS 145 
The study used a mixed methods approach consisting of 1) analysis of documents relating to research projects 146 
such as grant applications, annual reports, final reports; 2) a survey of researchers and PPI contributors; and 3) 147 
a workshop with eleven PPI contributors and the research team to discuss the findings and co-produce 148 
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recommendations.  The analysis of project documents was used to provide evidence of the scope of PPI in 149 
primary care research. The surveys were used to provide evidence on the quality, experiences, and impact of 150 
PPI. The findings informed the recommendations workshop and development of the cost-consequences 151 
framework. 152 
 153 
Setting 154 
This study focused on research projects funded by and taking place within the NIHR School of Primary Care 155 
Research (SPCR) since its inception in 2008 to 2014. This included all projects funded on each of the SPCR’s 156 
annual funding rounds (FR1 to FR8). The SPCR is a partnership between the leading academic centres for 157 
primary care research in England. Through dedicated funding, its remit is to increase the evidence base for 158 
primary care practice through high quality research and strategic leadership.  159 
 160 
Patient and public Involvement in this study 161 
The study embraced PPI throughout every stage of the research cycle, from developing the initial idea, 162 
designing the study and being lay co-applicants (AH, CR) on the grant application, through to working with the 163 
researchers to understand the findings and writing the recommendations. Full details of the involvement of 164 
the PPI contributors of our study team are published elsewhere [23]; however the contribution of our PPI 165 
contributors are embedded throughout this article. 166 
 167 
Analysis of project documents 168 
We requested all documentation relevant to all projects from the SPCR. This included grant applications, along 169 
with annual and final reports provided by grant holders to the SPCR. We also collected other documents 170 
containing data on PPI in projects from the SPCR and from researchers who had included PPI within their 171 
projects (e.g. posters presented at the annual SPCR Showcase event and articles).  172 
Data from the documents were recorded using a data extraction form and compiled in an electronic 173 
spread sheet. The type of data extracted from each document is shown in Table 1. Two members of the 174 
research team (SB, SM) completed the data extraction. To examine the scope of PPI in primary care research, 175 
the data from the project documents were summarised using descriptive statistics. We examined the change 176 
in the extent of PPI activities over time, using each annual funding round as a proxy measure of time. Subgroup 177 
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analyses were conducted to examine the frequency and type of PPI activity by study design, disease/condition 178 
(categorised using the Health Research Classification System [24]), study population, and the age profile of the 179 
study population. Descriptions and explanations relating to PPI were analysed qualitatively to provide further 180 
insight to the activities reported.  181 
 182 
[TABLE 1 Types of data extracted from the project documentation HERE] 183 
 184 
Researcher and PPI contributor surveys 185 
A cross-sectional survey design was employed using self-completed questionnaires. The researcher and PPI 186 
contributor questionnaires were developed through a review of the literature and a search for existing 187 
questionnaire items on the costs and consequences of PPI. The contribution of our three PPI contributors to 188 
develop the questionnaires ensured that items reflected the range of costs and consequences experienced by 189 
PPI contributors. The questionnaires included items aligning with Boote et al’s [25] quality indicators to enable 190 
the assessment of PPI activity against best practice (Table 2). Also, the questionnaire included items relating to 191 
the type of PPI activities and the perceived impact of these activities on the research study and the 192 
respondent. Most items included a free text box to allow the respondent to explain their answer or give 193 
further insights. The researcher and PPI contributor questionnaires are provided in Supplementary Files 1 and 194 
2, respectively.  195 
All Principal Investigators (lead researchers) of projects funded by the SPCR received an electronic 196 
survey via email for each project that they were leading or had led. Project details were provided by the SPCR. 197 
As the details of PPI contributors involved in SPCR projects were not available, an item was included in the 198 
researcher survey to determine Principal Investigators' willingness to pass on a paper-based questionnaire to 199 
the public members involved in their projects. Our PPI contributors were consulted about this recruitment 200 
strategy. They felt that, while possibly not ideal, particularly as this relied on good record keeping of public 201 
members’ involvement, this approach was pragmatic and acceptable. 202 
Descriptive statistics were calculated for all quantitative items in the survey: types of PPI activities, 203 
costs (financial and non-financial), and impacts. To examine the quality of PPI in primary care research, we 204 
compared PPI activity reported by Principal Investigators with Boote et al’s quality indicators of best practice 205 
[25]. The analysis focused on how many projects met each quality indicator. Two of Boote et al’s [25] quality 206 
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indicators related to the description and acknowledgement of PPI contributors’ involvement in publications. 207 
Therefore for the projects which the Principal Investigator in the survey reported PPI activities, we searched 208 
for related publications via the PubMed online search engine, using the Principal Investigator’s name and key 209 
words from project title as a search strategy. Retrieved publications were scrutinized for information relating 210 
to PPI. 211 
To explore whether projects with higher quality PPI (as defined by achieving a higher number of 212 
indicators of good practice, using Boote et al’s Quality Indicators [25]) was associated with a higher level of 213 
perceived impact, a quality-impact index score was also calculated for each project. A Pearson correlation 214 
coefficient was calculated between the number of quality indicators met (the quality score) and the number of 215 
PPI activities where Principal Investigators reported a perceived positive impact (the impact score).  216 
 217 
[TABLE 2 The principles and indicators of successful consumer involvement in NHS research. Adapted from 218 
Boote et al [25] HERE] 219 
 220 
A cost and consequences framework of PPI in primary care research 221 
Two researchers (PK, SJ) independently categorised survey items relating to the time spent on involvement 222 
activities and associated costs, impacts and related free text comments as either costs (financial and non-223 
financial) and consequences (benefits and harms). An overall framework of all potential financial and non-224 
financial costs and consequences of PPI was therefore constructed. 225 
 226 
Recommendations workshop 227 
Following completion of the data analysis, public members who had been previously involved with the project 228 
(AH, CR) plus seven other members of a Research User Group at Keele attended a workshop with the research 229 
team to discuss key findings of the study. The aim was to co-develop recommendations to improve PPI 230 
practice within the SPCR. 231 
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 232 
Ethical Approval 233 
Ethical approval was obtained from Keele University’s Research Ethics Committee (21st March 2014). 234 
 235 
RESULTS 236 
Documentary analysis 237 
A total of 200 full project proposals, 233 annual reports and 39 final reports were provided by the SPCR for the 238 
documentary analysis. The annual and final reports provided data on 180 projects; reports for the remaining 239 
20 projects were unavailable from the SPCR. However, for one project for which reports were not available to 240 
the research team, data on PPI were extracted from a poster presented at an SPCR Showcase Event. Therefore, 241 
the PPI activities reported in 181 projects were included in the analysis. 242 
 243 
Researcher and PPI contributor survey 244 
191 questionnaires were emailed to Principal Investigators, of which 46 were completed and returned 245 
(response rate 24%). The Principal Investigators who responded to the survey were unable to pass on a survey 246 
to the PPI contributors involved in their projects, so we did not collect any data from PPI contributors at this 247 
stage. Of the 46 responses received from Principal Investigators, 15 (33%) reported PPI activity, most 248 
commonly in designing methods (8 out of 15) and developing participant information (7 out of 15).   249 
   250 
1. Scope of PPI in primary care research 251 
1.1 PPI during the development of grant applications 252 
Of the 200 funded projects for which full grant applications were available, there was evidence of PPI in the 253 
development of the application for 47 (24%) projects. Just over half of the applications (113, 57%) provided 254 
evidence of plans to conduct PPI during the study.  Table 3 provides a summary of these projects by research 255 
design and health conditions under study. 256 
1.2 PPI during the projects 257 
Of the 181 projects for which annual and/or final project reports were available (plus one project whose 258 
information on PPI was extracted from a SPCR poster), 69 (38%) projects had been completed, 108 (60%) were 259 
uncompleted and this data was missing for three projects.  260 
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For all 181 projects (completed and uncompleted), PPI activities was reported for 84 projects (46%), not 261 
reported in 74 projects (41%), and for 23 projects (13%) there was insufficient data available to determine 262 
whether PPI had taken place or not. Where PPI had not been reported in the project, a rationale for the 263 
absence of PPI was provided for 26 projects (14%). 264 
In the case of the 108 uncompleted projects, PPI activities were planned for 36 projects (33% of 265 
uncompleted projects), there were no plans for PPI in 42 projects (39% of uncompleted projects), and there 266 
was insufficient information available to determine whether PPI was planned for the remaining 30 projects 267 
(18% of uncompleted projects). Where there were no plans for PPI, a rationale for this decision was provided 268 
for seven projects (7% of uncompleted projects).  269 
Rationales provided for 26 projects (completed and uncompleted) which did not report on PPI were 270 
similar, referring mostly to the applicability and relevance of PPI for the project. They included “user 271 
involvement was integrated into the original main trial, in which this project is nested. No additional user 272 
involvement was needed for the purposes of this project”; “this has been a database study and as a result 273 
there has been no direct involvement of patients or the public in this work”; “being a straightforward 274 
questionnaire study, PPI input to the project has been minimal”; or simply “not applicable”.  275 
1.3 Change in the scope of PPI over time 276 
There was no clear trend for an increase in PPI in the development of grant applications or the reporting of PPI 277 
in annual/final reports over time, using the SPCR funding rounds as a proxy measure of time. However, there 278 
was a trend for an increase over time in the percentage of project proposals which provided details of plans 279 
for PPI for the delivery of the research (R2=0.62) (Figure 1). 280 
 281 
[FIGURE 1 HERE] 282 
 283 
1.4 Budgeting for PPI 284 
Of the 113 grant applications that included plans for PPI during the study, 57 (50%) made reference to a 285 
budget for this and 32 (28%) referred to rewards and/or recognition for those who would be involved. There 286 
were no references to a budget for PPI in any of the annual/final reports or posters obtained from the SPCR, 287 
and only one reference to rewards and recognition for those involved. However, the research team did not 288 
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have access to the full costings for each project and it is therefore possible that this represents an 289 
underestimation of the number of projects for which PPI was budgeted. 290 
1.6 The scope of PPI by study design 291 
The extent of PPI varied across study design.  Across both grant applications and project reports, PPI was 292 
relatively more common for mixed methods, qualitative and interventional trial designs study designs 293 
compared to other study types (Table 3). Relatively, PPI was most prevalent in the development of grant 294 
applications for projects with a cross sectional design (4 of 7 projects, 57%). Evidence of PPI was relatively least 295 
frequent in cohort (longitudinal and retrospective), methodological (study of research methods or 296 
development of data collection systems), systematic reviews and analysis of secondary data study designs.  297 
When examining individual types of project documents, the data suggest a certain degree of 298 
inconsistency between planned and reported PPI. Plans for PPI within grant applications were relatively 299 
frequent for methodological and longitudinal cohort designs compared to other study types. However, 300 
reported PPI within annual/final reports was more common for cross sectional designs but less common for 301 
methodological design (as well as retrospective cohort and systematic reviews). 302 
1.7 The scope of PPI by health condition 303 
In terms of health condition researched, PPI in the development of grant applications and reported 304 
involvement during the study was relatively more common for projects focusing on cancer, renal and 305 
urogenital, reproductive health and childbirth (Table 3). PPI was most frequently planned for studies in the 306 
fields of neurology and other types of health conditions not listed in the Health Research Classification System 307 
[24] (labelled ‘Other’ in Table 3). However, evidence of PPI was relatively least frequent for studies on 308 
cardiovascular, metabolic and endocrine, stroke, infection and multimorbid (multiple, co-existing) health 309 
conditions. 310 
1.8 The scope of PPI by study population and age 311 
Though the study population of two-thirds of SPCR funded projects was patients only, projects focused on the 312 
general public, health care professionals only, and both patients and health care professionals, tended to have 313 
more PPI described in grant applications (both to develop the application and plans during the projects) (Table 314 
3). Except for the carers category, reported PPI during the study ranged from 38% (3 out of 15 projects on 315 
healthcare staff) to 65% of projects (20 out of 37 projects on patients and health care professionals) within 316 
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each population category. PPI was not reported in the annual and/or final reports of the single project 317 
involving carers.  318 
Inconsistencies were noted again between planned and reported PPI during the study across population 319 
categories. For example, for general public or health care professional study populations, the relative 320 
proportion of projects reporting PPI activities during the study in their annual/final reports was 30% lower 321 
than the proportion of projects with plans for PPI described in the grant applications.   322 
Projects focused on children tended to have less PPI described in proposals and annual/final reports 323 
compared to projects focusing on other age groups. For all other age groups PPI was similar: 20%-36% in the 324 
development of grant applications; 56%-64% in plans for PPI; 43%-56% reported PPI during the study. 325 
However, for nearly half of all projects (93, 47%), the age group of the study population was unspecified or 326 
difficult to ascertain from the project documents.  327 
 328 
[TABLE 3 PPI in SPCR projects, by study design, health condition, population and population age HERE] 329 
 330 
1.9 The type of PPI 331 
Of the 200 grant applications, PPI activities reported during the development of projects related to consulting 332 
with patients and members of the public and gaining their comments and feedback on plans for research (24 333 
projects, 12%) and contributing to the grant application (20 projects, 10%).  Advising on study methods, such 334 
as outcomes and recruitment methods, were specifically reported in 14 grant applications (7%). A range of 335 
planned PPI activities were outlined in the grant applications and reported in annual/final reports, relating to 336 
different stages of the research cycle (Figure 2).  Plans within grant applications for involvement in managing 337 
research through membership of a project steering committee or management group were most common (51 338 
projects, 26%), followed by involvement in dissemination of project findings (41 projects, 21%). Designing 339 
study methods, analysing/interpreting data and designing study materials (such as questionnaires) were also 340 
frequently planned involvement activities. Planned PPI in conducting the research and recruiting participants 341 
were the lowest areas of activity.   342 
However, the proportions of the PPI activities reported during the study were considerably lower than 343 
the planned activities described in grant applications. The most frequent activities reported during the project 344 
were designing study materials (33 projects, 18%), designing methods (25 projects, 14%) and managing the 345 
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research (17 projects, 9%).  To explore this inconsistency further, reports of PPI activities in project annual 346 
and/or final reports (either already conducted or plans to conduct for uncompleted projects) were compared 347 
with plans (and non-plans) for PPI outlined in their associated grant applications. This was done for 179 348 
projects where both the grant application and annual and/or final reports were available (Figure 3). Over a 349 
third of these 179 projects (65, 36%) reported the PPI activities as proposed in the grant applications, including 350 
27 projects (15%) which had no plans to do PPI anyway.  351 
However there was inconsistency for 70 projects (39%): 20 projects (11%) reported more PPI than 352 
originally planned; 50 projects (28%) reported less than originally planned (including 23 projects (13%) which 353 
did not do any of the PPI planned). Information on the discrepancies between planned and reported PPI 354 
activities was not available in the project documentation. In most cases where more PPI was reported that 355 
originally planned, the annual and/or final reports documented PPI activities that was not part of a project’s 356 
grant application. It is speculated that any additional PPI was conducted as the project evolved and new 357 
opportunities for involvement were created.  For 64 projects (35%), the annual and/or final reports made 358 
either no reference to the PPI activities planned in the grant application, or made references to a few PPI 359 
activities only, but not all that were planned.  It is possible that for some of the uncompleted projects, plans 360 
for future PPI activities outlined in the grant application but not yet done were not reported. For six projects 361 
(3%), however, it was explained in the reports that ‘[the] PPI member no longer want[ed] to be involved in the 362 
study’; there was less PPI than planned because ‘it was a highly technical study and utilised anonymous clinical 363 
data with no direct patient contact’; there has been “no real PPI in the project…and the PPI section is not 364 
applicable since the project involved a secondary analysis of a database with specific policy relevant 365 
questions”; and "not applicable" or “none” was provided in the PPI section of the final report (3 projects, 2%). 366 
There was insufficient information to make a judgement on the consistency of planned versus reported 367 
PPI for 44 other projects (25%). In most of these, the nature of the PPI could not be determined due to the 368 
insufficient information about PPI provided in either the grant application or the annual and/or final reports.  369 
 370 
[FIGURE 2 HERE] 371 
[FIGURE 3 HERE] 372 
 373 
2. Quality of PPI in primary care research 374 
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The quality of PPI was assessed using the data from the 15 Principal Investigators who responded to our survey 375 
and reported PPI in their project. Overall, there was variation in how best practice, according to the quality 376 
indicators reported by Boote et al [25], was met across studies (Figure 4). Best practice was more frequently 377 
achieved in terms of offering PPI contributors personal and technical support (13 out of 15 projects, 87%); 378 
involving PPI contributors in advising on recruitment issues (11 out of 15 projects, 73%) and having a specific 379 
budget for PPI (9 out of 15 projects, 60%). Fewer studies met best practice for PPI in terms of PPI contributors 380 
advising on informing participants about study progress (1 out of 15 projects, 7%); advising on dissemination 381 
methods (1 out of 15 projects, 7%) or having to access to training (3 out of 15 projects, 20%). We could not 382 
provide evidence towards the endorsement of the quality indicators: ‘PPI training needs are agreed’ (this was 383 
to be captured via the patient survey) and ‘Distribution of research findings to relevant patient groups was in 384 
appropriate formats and easily understandable language’. 385 
 386 
[FIGURE 4 HERE] 387 
 388 
3. The impact of PPI from the researcher’s perspective 389 
Principal Investigators most commonly reported impact for study processes with the most PPI activity (i.e. 390 
designing methods and developing participant information). Perceived impact of PPI on the research process 391 
and individual Principal Investigators was largely positive and included benefits such as improving the clarity of 392 
information, increased recruitment and follow-up rates, validation of findings and more useful outputs for 393 
clinicians and patients. The only negative impact reported was the view that a more homogenous study 394 
sample may have been recruited, since the young PPI contributors encouraged their friends to participate in a 395 
study on reproductive health in young people. Despite reported PPI activity in developing the grant application 396 
(3 out of 15, 20%), managing the research (3 out of 15, 20%), and conducting the research (2 out of 15, 13%), 397 
Principal Investigators reported minimal perceived impact in these areas.  398 
No Principal Investigators reported a negative impact of PPI on them personally but most (10 out of 399 
15, 67%) believed that it had little impact on the reputation of their institution. However, most researchers (13 400 
out of 15, 87%) reported that they would engage with PPI in their research again, regardless of whether or not 401 
it was a requirement set down by funders. From the free text responses in the questionnaire, some 402 
researchers expressed a positive impact of PPI: 403 
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 404 
 “Very helpful in helping me gain a better understanding of the issues involved with [disease]” (PI119) 405 
“Feedback from patient representatives raised some key concerns which were important to address in our 406 
branding and overall presentation from the outset” (PI116) 407 
“[PPI] provide a reality check on patient benefit of research, broaden perspectives and focus on the lived 408 
experience” (PI89) 409 
 410 
A few principal investigators offered some alternative experiences and less positive viewpoints of PPI in 411 
research: 412 
 413 
“Sometimes patients are really helpful and give good ideas and have good contacts. I am sorry to be cynical but 414 
it is also a requirement for funders so you HAVE to do it” (PI70) 415 
 “Young people can be unreliable – it’s sometimes difficult to know whether they will turn up or not, and to plan 416 
accordingly.” (PI90) 417 
 418 
While the respondent in the above quote has commented on young people, it should be noted, however, that 419 
this is not generalizable of all young PPI contributors. The participation of all PPI contributors can be impacted 420 
by many factors, such as availability on scheduled meeting dates, changes in health status and other 421 
commitments.  422 
3.1 Quality-Impact Index scores 423 
Figure 5 shows the Quality-Impact Index scores based on the Principle Investigators’ responses relating to the 424 
quality and impact of PPI activities for the 15 projects included in the research survey. There was a moderate 425 
positive correlation between the Quality Score (number of quality indicators met by a project) and Impact 426 
Score (number of PPI activities in which the PI reported a perceived impact) (Pearson correlation coefficient, r 427 
= .50, p = .056). Though statistically insignificant, this results suggests a greater perceived impact of PPI activity 428 
for projects where a higher number of quality indicators for PPI were met. 429 
 430 
[FIGURE 5 HERE] 431 
 432 
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4. The financial costs of PPI 433 
The most significant cost from a researcher perspective appeared to be the researcher’s time. However, 434 
researchers reported a variable numbers of hours related to PPI, ranging from 0 to 30 hours as a total across 435 
all activities.   436 
Half of Principal Investigators (8 out of 15, 53%) reported that they ‘Always’ or ‘Sometimes’ offered 437 
some form of payment to PPI contributors and a third (5 out of 15, 30%) reimbursed expenses. Principal 438 
Investigators reported that public members received payment for attending meetings (6 out of 15, 40%), 439 
reviewing documents in their own time (2 out of 15, 13%) and attending events (1 out of 15, 7%). Payment for 440 
other activities (e.g. conducting the research, responding to letters and emails from researchers) was not 441 
reported. Travel costs (e.g. car mileage, public transport, parking) and food and drink were the only expenses 442 
reimbursed. 443 
However, few studies were able to confirm the actual financial costs associated with PPI. A third of 444 
the respondents reported difficulty in providing general information about PPI in their project(s) (5 out of 15, 445 
30%) and almost half (7 out of 15, 47%) found it difficult to give information relating to the costs of PPI. Free 446 
text responses indicated that the researchers did not keep records of the costs associated with PPI activity in 447 
their projects. Due to the overall lack of systematic recording of resourcing PPI activity and the time lag for 448 
some of the older projects in the sample, the responses of the Principal Investigators on the costs and time 449 
commitment of PPI are likely to be underestimated. 450 
 451 
5. A new Cost and Consequences Framework of PPI in research 452 
Table 4 presents a framework of the individual costs and consequences for both the research/researcher and 453 
patient. Responses from the researcher survey provided information for the costs and consequences 454 
framework under sub-headings of researcher, research project, research institution and funder. As no 455 
responses were received for the patient survey, costs and consequences identified from the literature are 456 
included in the framework.   457 
 458 
[TABLE 4 Costs and Consequences Framework HERE] 459 
 460 
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6. Recommendations workshop 462 
Following the data analysis by the research team, public members who had been previously involved with the 463 
project plus other members of a Research User Group at Keele attended a workshop. The aim was to co-464 
produce recommendations to improve PPI practice within the SPCR. Three PPI contributors of the study, eight 465 
other members of the Research User Group at Keele and the research team came together to discuss as a 466 
group the key findings of the study and consider recommendations to address the findings, build upon existing 467 
good practice and improve PPI in research. During the workshop consensus was achieved on the general 468 
content of the recommendations. Following the workshop, the research team mapped the recommendations 469 
to those in the NIHR ‘Going the Extra Mile’ report [3], INVOLVE’s “Values and Principles Framework’ [4] and 470 
the SPCR strategy for PPI [26]. To ensure consistency with these national priorities and directions, the research 471 
team refined the final wording of our recommendations, which were reviewed and agreed upon by our PPI 472 
contributors (Table 5).   473 
 474 
[TABLE 5 Recommendations for improving the practice and delivery of PPI in research HERE] 475 
 476 
DISCUSSION 477 
This is the first study to systematically investigate the quality and impact of PPI across a wide cohort of primary 478 
care research studies.  Furthermore, we have applied recognised quality indicators to assess the quality of PPI 479 
and linked the level of quality with its perceived impact on the research process. We have also identified and 480 
developed a framework of the costs (financial and non-financial) and consequences of PPI in primary care 481 
research.  This should enable others to assess the impact of different approaches to PPI on key research 482 
outcomes and the people involved.    483 
Previous studies have tended to focus on scope and impact, i.e. what PPI has taken place and how this 484 
may or may not have made a difference to the research process. However, knowing the quality of PPI (or how 485 
well it has been undertaken) is just as essential. New Standards for Public Involvement are expected in 2018 486 
[27]. INVOLVE have published resources on good practice and approaches to PPI, including a Values and 487 
Principles Framework [4]. There are a few appraisal guidelines and frameworks for assessing the quality of PPI 488 
[25, 28], including a recently published framework designed to help researchers to recognise the ethical issues 489 
when involving the public during the design of research studies [29]. In particular, Boote et al. [25] produced 490 
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eight principles of successful PPI in NHS research, with each principle having at least one clear and valid 491 
indicator (or measure) of good practice (Table 2). Furthermore, the GRIPP2 (Guidance for Reporting 492 
Involvement of Patients and Public) checklist has been developed to enhance the quality of PPI reporting [16].  493 
Nevertheless, we are not aware of any studies that have formally evaluated the quality of PPI in research.  494 
Our study has shown that PPI has not been routinely undertaken across SPCR-funded research 495 
studies. While some have included PPI at different stages of research, most projects have not in either 496 
developing the grant application, and/or whilst conducting the research, or both. This does not seem to have 497 
improved over time, despite becoming a requirement of funding.  PPI was reported most frequently in the 498 
management of studies (e.g. steering group membership), and designing study materials (e.g. questionnaires) 499 
and methods (e.g. recruitment strategy, intervention design), but less frequently for other aspects of the 500 
research process (e.g. developing and reviewing participant information leaflets, commenting on the study 501 
protocol, conducting the research, developing future research areas). Similar studies on the extent and type of 502 
PPI have reported similar findings [5, 6].  Furthermore, the extent of PPI in primary care research was 503 
inconsistent across research design, with PPI seemingly less prevalent in study designs where there was less 504 
direct contact with patient/participants during the study. The wide variability of PPI across health research 505 
topics identified in this study is difficult to interpret or provide reasons for but our findings suggest that the 506 
level of PPI in the research of some health conditions is markedly lower.  These findings indicate that greater 507 
awareness of the value of PPI throughout the research cycle, across research designs and in different health 508 
conditions is required.  509 
The quality of PPI reported by Principal Investigators did not always meet guidelines for best practice.  510 
Though there were a few projects which conducted good quality PPI, findings from our researcher survey 511 
highlighted particular areas where best practice was not being followed. For example, in a number of projects 512 
PPI contributors were not offered payment for their time or reimbursement of expenses; and few projects 513 
documented the role of PPI contributors or engaged with them regarding the dissemination of research 514 
findings. We assessed quality in terms of meeting indicators of good practice. While, we were not able to 515 
identify specific examples of poor practice in either the analysis of project documents or the researcher survey, 516 
we did find that researchers spent variable amounts of time on PPI activities during a study (ranging 0 to 30 517 
hours). This suggests that those who spent fewer or minimal hours on PPI may not have taken sufficient time 518 
to have meaningfully engaged with the public.  519 
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Furthermore, whilst we acknowledge that not all of Boote et al’s quality indicators may be relevant 520 
for all study types (e.g. obtaining advice from PPI contributors on recruitment issues may not be relevant for 521 
studies where there is no participant recruitment, such as systematic reviews or some cohort studies) they 522 
provide a benchmark of quality that ought to be achieved if a study involved members of the public. This study 523 
was conducted before INVOLVE’s Values and Principles Framework was published [4]. However, most of Boote 524 
et al quality indicators are incorporated in some form or another within this new framework and the soon to 525 
be launched Standards for Public Involvement [27] . Yet it is too early at this stage to tell how INVOLVE’s 526 
Values and Principles Framework will be used in practice and/or how well the National Standards for Public 527 
Involvement might be used to assess and improve the quality of PPI. Nevertheless, future studies should 528 
consider how the National Standards for Public Involvement, GRIPP2 reporting checklist and other PPI 529 
resources and tools complement each other, in the context of the costs and consequences of PPI highlighted in 530 
this study. This should help drive forward improvements in this field in a coherent and consistent way. For 531 
example the financial and non-financial costs of PPI highlighted in this study should be considered when using 532 
INVOLVE’s Budgeting for Involvement Cost Calculator.  533 
Our survey highlighted that researchers found it difficult to provide information on PPI and its costs. 534 
We have also shown that it is difficult to contact public members who have been involved in research, as 535 
researchers were unable to pass the PPI contributor survey to those involved in their research. Reasons for are 536 
not entirely clear and we are not aware of similar findings in the literature. Some researchers reported that 537 
they did not have this information. So it is possible that the researchers and/or their organisations did not 538 
systematically and routinely keep records of PPI activity (or at least were not able to readily access these 539 
records at the time of completing the survey). This could be due, in part, to a possible lack of administrative 540 
support in some organisations.  541 
A key finding of this study was the inconsistency between the plans to conduct PPI during a study and 542 
the reported delivery of that activity. The fact that PPI activities were often different to those described in 543 
research proposals - and sometimes planned PPI was not conducted at all - is problematic. Mathie et al also 544 
reported a lack of documentation providing evidence of monitoring or how the PPI strategy within a study may 545 
have changed as the research develops [5]. This suggests a need for research funders to keep a check on PPI 546 
activity within research projects and to help researchers to make realistic plans for PPI at the outset. 547 
This study complements the results of similar studies: 548 
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• Mixed methods design and interventional trials tended to have the most PPI compared to other 549 
research designs [5, 6]. PPI was less common in observational and cohort studies [5]. 550 
• The most commonly stated PPI activity was membership of steering committees and reviewing 551 
patient information leaflets [5, 6] 552 
• Increased time in building relationship with PPI contributors and planning and managing PPI is a major 553 
consideration for researchers [6, 10, 11, 12]  554 
• There is limited amount of available information about PPI in publicly accessible research documents 555 
[5] 556 
 557 
The limitations to this study include:  558 
1. A low response rate to the researcher survey (24%). While this is in line with similar studies [5], the length of 559 
questionnaire and the approximate 45 minute completion time may have been a barrier to participation. 560 
Nevertheless, the level of detail was necessary to obtain a comprehensive understanding of PPI in primary care 561 
research.  Secondly, some researchers commented that it was difficult to recall details of the PPI in studies that 562 
may have begun as early as 2008.  563 
2. Although it is not unreasonable to suggest that the direct costs of PPI (e.g. payment to individuals, 564 
reimbursement of expenses, room hire, etc.) could and should be recorded, it is likely that financial systems 565 
differ across universities, and there may also be problems, particularly in terms of workload, obtaining access 566 
to that level of detail once a project has been completed.     567 
3. Data from the documentary analysis was inconsistent due to changes in the SPCR application and reporting 568 
forms over the funding rounds. Nevertheless, many of the annual/final reports contained very little 569 
information, and were incomplete or ambiguous. This highlights a problem with recording and reporting of PPI 570 
activity. This made extracting data difficult and the research team sometimes made a judgement by consensus 571 
as to the meaning of the information.  572 
4. We were not able to conduct the PPI contributor survey as we experienced difficulties with accessing PPI 573 
contributors to invite them to participate. As the contact details of PPI contributors involved with SPCR work 574 
were not available, we decided to ask Principal Investigators to pass the survey to PPI contributors who had 575 
been involved in their projects.  Unfortunately, all Principal Investigators who responded to the survey were 576 
either unable (due to lack of recorded contact information) to pass on the postal survey to PPI contributors. 577 
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This meant that we were unable to gather data on the costs and consequences of involvement from PPI 578 
contributors. However, members of the Research User Group at Keele were involved in the analysis of the data 579 
and the development of recommendations to ensure some representation of the patient and public 580 
perspective.  581 
4. We originally planned to observe PPI in research studies.  In the final section of the survey, Principal 582 
Investigators were asked to indicate whether they had any forthcoming meetings with PPI planned, and if so 583 
whether they were happy for two researchers to observe the meeting. Unfortunately, most respondents did 584 
not have any meetings with PPI planned, and one respondent was not willing for us to observe their meeting.    585 
 586 
Role of PPI in the study 587 
Public members have played a fundamental role in shaping the project, from the initial development of the 588 
research idea to the dissemination and implementation of findings. The role of PPI has been described and 589 
embedded through this article. In addition to the activity already described, there has also been involvement 590 
in the dissemination of early project findings with a PPI contributor co-presenting with a researcher at the 591 
INVOLVE Conference 2014. Two lay co-applicants were invited to comment on and contribute to the plain 592 
English summary of this article and the final project report to the SPCR. They also commented on their 593 
experience of the research study and their views of its findings (Table 6).  594 
While this study was funded by the SPCR, we did not include it as part of the analysis of 595 
documentation and surveys in order to remain independent. However, we worked with our PPI contributors 596 
(AH, CR) to conduct our own self-assessment of the quality of PPI in this study against Boote et al’s quality 597 
indicators [25] as a separate exercise (Additional File 3).  We achieved 10 out of the 11 quality indicators. This 598 
suggests the PPI in this study was of high quality.  The single indicator not achieved was PPI in advising on 599 
informing participants about study progress. This might have been achieved if the survey of PPI contributors 600 
had been completed.   601 
Furthermore, to highlight the benefits and challenges of PPI experienced, we produced our own Cost 602 
and Consequences Framework for this study (see Additional File 4). This provides an example of the use of the 603 
Cost and Consequences Framework in practice. We have included relevant items about the PPI activity that we 604 
experienced during the course of this study. We have not included items relating to ‘researchers gaining a 605 
better understanding of the condition of interest’ as this was not a study of a particular health condition. The 606 
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exercise has identified areas that we need to be aware of and improve on in future studies involving PPI 607 
contributors (e.g. ensuring all PPI activities are fully costed and budgeted), and many benefits of PPI that need 608 
to be reported and shared (e.g. PPI as a motivating factor, with PPI contributors bringing an enthusiasm to the 609 
project, and a keenness to see results). 610 
[TABLE 6 Experience of lay co-applicants and co-authors (CR, AH) regarding their involvement in this study and 611 
its findings HERE] 612 
[Additional File 3 Self-assessment of the quality of PPI for this study HERE] 613 
[Additional File 4 A Cost and Consequences Framework for this study HERE] 614 
 615 
Future impact of this study 616 
The results of this study have provided a detailed account of PPI within primary care research and have shown 617 
the variability of PPI in projects to date. In particular, findings have highlighted areas for improvement in PPI. 618 
This has led to the development of recommendations for good PPI practice, in collaboration with members of 619 
a Research User Group, to ensure that the patient perspective is represented.  Implementation of these 620 
recommendations, which complement the NIHR ‘Going the Extra Mile’ report [3], INVOLVE’s “Values and 621 
Principles Framework’[4], Standards for Public Involvement [27] and the NIHR School for Primary Care 622 
Research (SPCR) PPI Strategy [26], will ensure that PPI activities meet quality indicators and that standardised 623 
records of PPI activities are kept to facilitate the evaluation of impact. The new Costs and Consequences 624 
Framework considers many potential benefits, harms and costs (financial and non-financial) of PPI which will 625 
help others assess the wider impacts of PPI. Further, the surveys developed within the project can be used by 626 
the SPCR and others to collect detailed data on the costs and consequences of PPI in future projects and also 627 
alter grant application forms and project reports to improve reporting of PPI activities.                                                                                                                                                                                                                                                                                                                                                                                                                                                       628 
 629 
CONCLUSION 630 
PPI in primary care research is inconsistent in terms of its extent, nature and quality across research design 631 
and topics.  There is scope for improvement in terms of:  632 
1) establishing the costs and consequences for researchers and PPI contributors of involvement in 633 
research 634 
2) recording and reporting the contribution and impact of PPI  635 
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3) promoting and implementing best practice, and PPI.  636 
This study did identify pockets of good practice and this tended to be reported as making a positive impact 637 
on researchers and research studies. We were unable to access PPI contributors to obtain their views and 638 
experiences. Nevertheless, the public perspective, through PPI involvement in our study, was instrumental in 639 
interpreting the findings and co-producing recommendations to improve PPI in primary care research. The 640 
findings of this study have informed a cost and consequences framework which may help others assess the 641 
impact of PPI.  642 
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i We have used the term ‘PPI contributors’ to collectively describe members of the public actively involved in 684 
research projects, including patients, members of the public, service users and carers. 685 
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TABLES 760 
Table 1 Types of data extracted from the project documentation 761 
 Study design 
 Disease/condition studied  
 Study population 
 SPCR funding round 
 Presence of a section dedicated to PPI within the document 
 Presence of PPI in the development of the grant application (including a description of the type and 
number of public members involved) 
 Description of plans for PPI (including a description of the type and number of public members 
involved) 
 Details of PPI activities conducted 
 Explanation for any lack of PPI 
 References to a specific budget for PPI 
 References to rewards and recognition for involvement. 
 Level of consistency between planned and reported PPI activities was noted (including 
explanations for any discrepancies). 
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Table 2 The principles and indicators of successful consumer involvement in NHS research. Adapted from 764 
Boote et al [25] 765 
  Principle Indicator(s) 
1 The roles of consumers are agreed 
between the researchers and consumers 
involved in the research 
The roles of consumers in the research were 
documented 
2 Researchers budget appropriately for the 
costs of consumer involvement in research 
Researchers applied for funding to involve 
consumers in the research 
Consumers were reimbursed for their travel costs 
Consumers were reimbursed for their indirect 
costs (e.g. carer costs) 
3 Researchers respect the differing skills, 
knowledge and experience of consumers 
The contribution of consumers’ skills, knowledge 
and experience were included in research reports 
and papers 
4 Consumers are offered training and 
personal support, to enable them to be 
involved in research 
Consumers’ training needs related to their 
involvement in the research were agreed between 
consumers and researchers 
Consumers had access to training to facilitate 
their involvement in the research 
Mentors were available to provide personal and 
technical support to consumers 
5 Researchers ensure that they have the 
necessary skills to involve consumers in the 
research process 
Researchers ensured that their own training needs 
were met in relation to involving consumers in the 
research 
6 Consumers are involved in decisions about 
how participants are both recruited and 
Consumers gave advice to researchers on how to 
recruit participants to the research 
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kept informed about the progress of the 
research 
Consumers gave advice to researchers on how to 
keep participants informed about the progress of 
the research 
7 Consumer involvement is described in 
research reports 
The involvement of consumers in the research 
reports and publications was acknowledged 
Details were given in the research reports and 
publications of how consumers were involved in 
the research process 
8 Research findings are available to 
consumers, in formats and in language 
they can easily understand 
Research findings were disseminated to 
consumers involved in the research in appropriate 
formats (e.g. large print, translations, audio, 
Braille) 
The distribution of the research findings to 
relevant consumer groups was in appropriate 
formats and easily understandable language 
Consumers involved in the research gave their 
advice on the choice of methods used to 
distribute the research findings 
 766 
 767 
  768 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
 31 
 
Table 3 PPI in SPCR projects, by study design, health condition, population and population age.   769 
 Projects (Grant 
applications) 
 Projects with evidence of 
PPI in developing the grant 
application  
(N=200) 
 Projects with evidence of 
plans for PPI during the study 
in the grant application 
(N=200) 
 Projects 
(Annual/ Final 
Reports)a 
 Projects with evidence of 
PPI reported in annual/final 
reports (N=181) 
 n (%)  n (%) (Relative 
%)b 
 n (%) (Relative %)b  n (%)  n (%) (Relative %)c 
All Projects 200 (100)  47 (23.5)   113 (56.5)   181 (181)  83 (46.1)  
Study Design                  
Mixed methods  47 (23.5)  15 (7.5) (31.9)  30 (15.0) (63.8)  39 (21.5)  24 (13.3) (61.5) 
Qualitative 36 (18.0)  9 (4.5) (25.0)  23 (11.5) (63.9)  30 (16.6)  17 (9.4) (56.7) 
Longitudinal cohort 29 (14.5)  5 (2.5) (17.2)  18 (9.0) (62.1)  29 (16.0)  11 (6.1) (37.9) 
Intervention trial 25 (12.5)  6 (3.0) (24.0)  15 (7.5) (60.0)  23 (12.7)  14 (7.7) (60.9) 
Systematic reviews 17 (8.5)  2 (1.0) (11.8)  7 (3.5) (0.0)  17 (9.4)  2 (1.1) (11.8) 
Retrospective cohort 13 (6.5)  2 (1.0) (15.4)  4 (2.0) (30.8)  13 (7.2)  3 (1.7) (23.1) 
Secondary analysis 8 (4.0)  0 (0.0) (0.0)  4 (2.0) (50.0)  8 (4.4)  3 (1.7) (37.5) 
Cross sectional 7 (3.5)  4 (2.0) (57.1)  3 (1.5) (42.9)  7 (3.9)  4 (2.2) (57.1) 
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 Projects (Grant 
applications) 
 Projects with evidence of 
PPI in developing the grant 
application  
(N=200) 
 Projects with evidence of 
plans for PPI during the study 
in the grant application 
(N=200) 
 Projects 
(Annual/ Final 
Reports)a 
 Projects with evidence of 
PPI reported in annual/final 
reports (N=181) 
 n (%)  n (%) (Relative 
%)b 
 n (%) (Relative %)b  n (%)  n (%) (Relative %)c 
Methodological 5 (2.5)  1 (0.5) (20.0)  4 (2.0) (80.0)  4 (2.2)  1 (0.6) (25.0) 
Case control 4 (2.0)  0 (0.0) (0.0)  1 (0.5) (25.0)  3 (1.7)  0 0 (0.0) 
Multi-stage studyd 4 (2.0)  2 (1.0) (50.0)  2 (1.0) (50.0)  2 (1.1)  2 (1.1) (100) 
Individual participant 
meta analysis 
3 (1.5)  0 (0.0) (0.0)  1 (0.5) (33.3)  2 (1.1)  1 (0.6) (50.0) 
Othere 2 (1.0)  1 (0.5) (50.0)  1 (0.5) (50.0)  4 (2.2)  2 (1.1) (50.0) 
Health Condition Under 
Study 
                 
General Health 28 (14.0)  9 (4.5) (32.1)  14 (7.0) (50.0)  22 (12.2)  9 (0.0) (40.9) 
Cardiovascular 27 (13.5)  4 (2.0) (14.8)  16 (8.0) (59.3)  28 (15.5)  10 (5.5) (35.7) 
Mental Health 21 (10.5)  5 (2.5) (23.8)  12 (6.0) (57.1)  17 (9.4)  11 (6.1) (64.7) 
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 Projects (Grant 
applications) 
 Projects with evidence of 
PPI in developing the grant 
application  
(N=200) 
 Projects with evidence of 
plans for PPI during the study 
in the grant application 
(N=200) 
 Projects 
(Annual/ Final 
Reports)a 
 Projects with evidence of 
PPI reported in annual/final 
reports (N=181) 
 n (%)  n (%) (Relative 
%)b 
 n (%) (Relative %)b  n (%)  n (%) (Relative %)c 
Cancer 16 (8.0)  7 (3.5) (43.8)  8 (4.0) (50.0)  16 (8.8)  10 (5.5) (62.5) 
Metabolic and 
Endocrine 
14 (7.0)  1 (0.5) (7.1)  6 (3.0) (42.9)  16 (8.8)  9 (5.0) (56.3) 
Musculoskeletal  14 (7.0)  3 (1.5) (21.4)  6 (3.0) (42.9)  13 (7.2)  6 (3.3) (46.2) 
Respiratory 13 (6.5)  3 (1.5) (23.1)  6 (3.0) (46.2)  12 (6.6)  5 (2.8) (41.7) 
Multimorbidity 7 (3.5)  0 (0.0) (0.0)  1 (0.5) (14.3)  8 (4.4)  3 (1.7) (37.5) 
Stroke 7 (3.5)  1 (0.5) (14.3)  3 (1.5) (42.9)  5 (2.8)  2 (1.1) (40.0) 
Infection 5 (2.5)  1 (0.5) (20.0)  3 (1.5) (60.0)  5 (2.8)  1 (5.0) (20.0) 
Renal and Urogenital 5 (2.5)  2 (1.0) (40.0)  5 (2.5) (100)  5 (2.8)  3 (1.7) (60.0) 
Reproductive Health 
and Childbirth 
5 (2.5)  2 (1.0) (40.0)  5 (2.5) (100)  5 (2.8)  4 (2.2) (80.0) 
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 Projects (Grant 
applications) 
 Projects with evidence of 
PPI in developing the grant 
application  
(N=200) 
 Projects with evidence of 
plans for PPI during the study 
in the grant application 
(N=200) 
 Projects 
(Annual/ Final 
Reports)a 
 Projects with evidence of 
PPI reported in annual/final 
reports (N=181) 
 n (%)  n (%) (Relative 
%)b 
 n (%) (Relative %)b  n (%)  n (%) (Relative %)c 
Neurological 3 (1.5)  0 (0.0) (0.0)  3 (1.5) (100)  1 (0.6)  1 (0.6) (100) 
Cancer, Mental Health 1 (0.5)  1 (0.5) (100)  0 (0.0) (0.0)  1 (0.6)  1 (0.6) (100) 
Inflammatory and 
Immune System 
1 (0.5)  0 (0.0) (0.0)  0 (0.0) (0.0)  0 (0.0)  0 (0.0)  
Oral and 
Gastrointestinal 
1 (0.5)  0 (0.0) (0.0)  0 (0.0) (0.0)  1 (0.6)  0 (0.0) (0.0) 
Skin 1 (0.5)  1 (0.5) (100)  1 (0.5) (100)  1 (0.6)  1 (0.6) (100) 
Otherf 31 (15.5)  7 (3.5) (22.6)  24 (12.0) (77.4)  23 (12.7)  8 (4.4) (34.8) 
Study population  
                 
Patients 134 (67.0)  26 (13.0) (19.4)  68 (34.0) (50.7)  123 (68.0)  54 (29.8) (43.9) 
Patients & HCPs 37 (18.5)  11 (5.5) (29.7)  24 (12.0) (64.9)  31 (17.1)  20 (11.0) (64.5) 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
 35 
 
 Projects (Grant 
applications) 
 Projects with evidence of 
PPI in developing the grant 
application  
(N=200) 
 Projects with evidence of 
plans for PPI during the study 
in the grant application 
(N=200) 
 Projects 
(Annual/ Final 
Reports)a 
 Projects with evidence of 
PPI reported in annual/final 
reports (N=181) 
 n (%)  n (%) (Relative 
%)b 
 n (%) (Relative %)b  n (%)  n (%) (Relative %)c 
Healthcare 
professionals (HCPs) 
15 (7.5)  5 (2.5) (33.3)  10 (5.0) (66.7)  8 (4.4)  3 (1.7) (37.5) 
General public 13 (6.5)  5 (2.5) (38.5)  10 (5.0) (76.9)  15 (8.3)  7 (3.9) (46.7) 
Carers 1 (0.5)  0 (0.0) (0.0)  1 (0.5) (100)  1 (0.6)  0 (0.0) (0.0) 
Study population age 
                 
Unspecified 93 (46.5)  19 (9.5) (20.4)  54 (27.0) (58.1)  83 (45.9)  35 (19.9) (43.4) 
Adult (18+ years) 89 (44.5)  24 (12.0) (27.0)  50 (25.0) (56.2)  83 (45.9)  42 (23.2) (50.6) 
Adult and Children 11 (5.5)  4 (2.0) (36.4)  7 (3.5) (63.6)  9 (5.0)  5 (2.8) (55.6) 
Children and young 
adults (0 – 17 years)g 
7 (3.5)  0 (0.0) (0.0)  2 (1.0) (28.6)  6 (3.3)  1 (0.6) (16.7) 
a Included one project whose data on PPI was obtained from an SPCR poster; b Percentage relative to the number of projects in each category in grant applications ; c 770 
Percentage relative to the number of projects in each category in annual/final reports; d Multi-stage studies included case control and intervention trial (1), cross sectional 771 
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and longitudinal cohort (1), systematic review and longitudinal cohort (1), systematic review and secondary analysis; e Included projects to set up and maintain a SPCR PPI 772 
group (1) and a preliminary descriptive study (1); f Conditions not classified under the Health Research Classification System [24]; g It was not always possible to determine 773 
the ages or age range of children from the study documentation. Sometimes, ages were provided, sometimes the documentation referred to ‘children’. So we have 774 
assumed children and young adults to be 17 and under. 775 
 776 
  777 
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Table 4 Costs and Consequences Framework 778 
Impact upon Costs (-) Benefits (+) 
Researcher - Time (recruiting PPI contributors; travelling to meet with 
PPI contributors; meetings; electronic communication; 
preparing newsletters) 
- Increased pressure/stress 
- Sensitivity to criticism 
+ A motivating factor, with PPI contributors bringing an 
enthusiasm to the project, a keenness to see results 
+ PPI contributors supportive of the project 
+ Researchers gaining a better understanding of the 
condition of interest 
Research 
Project 
Shaping the research 
question and maintaining 
focus 
 + Setting and maintaining focus on the research question 
+ Addressing important issues but also ensuring a degree 
of realism 
Research methods/design - Can result in duplication of effort (PPI involvement and 
qualitative work) 
+ Helping to make surveys and processes relevant, 
accessible and acceptable 
+ Ensuring research is beneficial to patient group 
Recruitment & recruitment 
materials 
- Potentially homogenous sample + Relevance, clarity & accessibility of recruitment materials 
+ Making useful contacts, increasing recruitment rates 
Conducting & managing 
research 
- PPI contributors can be unreliable (this was reported in 
the case of young people) 
+ Validity and safety of research 
+ Improved follow-up rates 
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- Direct payment of PPI contributors for attending 
meetings  
- Travel costs (either the researcher visiting the PPI 
representative or the PPI representative attending 
meetings1)  
- Food and refreshment costs  
- External venues 
Commenting on results  + Opportunities to gain feedback and to validate the 
results. 
+ PPI contributors helping to interpret the data. 
Dissemination - Financial cost of PPI contributors attending conferences 
and external events 
+ Promotion of outputs when these take the form of 
training modules or tool kits 
+ Guidance in terms of presenting results in a format useful 
to non-researchers. 
Generating new research 
questions (expanding upon 
current research) 
 + Generating new/future research questions 
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Research Institution - Diversion of research funds to PPI (opportunity cost in 
terms of funded researcher time, etc.) 
- IT and other support infrastructures/resources (including 
printing & internal room bookings) 
+ Increased impact of research 
+ Recognition as a centre with expertise and experience of 
involving patients and public in research (raising the 
institution’s profile) 
Funder  + Avoiding devoting resources to a topic which is not 
important (e.g. exploring an intervention which is not 
appealing to service users) 
PPI contributors - Opportunity cost (paid work, child care, informal care & 
leisure time) 
- Monetary costs not reimbursed (travel, formal child care) 
- Negative impact on health associated with stress, anxiety 
or frustration 
- Complications in terms of state provided welfare 
payments 
+ Increased understanding & knowledge of one’s own 
condition  
+ Increased awareness of treatment options and how to 
access services 
+ Developing or enhancing skills (e.g. public speaking, team 
work, IT) – possibly through formal training 
+ Understanding of research and research processes 
+ Positive emotional impact associated with meeting new 
people, feeling as though one is doing something 
worthwhile and generally being active 
 779 
1 Sometimes included within the direct payment 780 
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Entries in italics were identified from the literature but not verified by respondents 781 
  782 
 783 
 784 
Table 5 Recommendations for improving the practice and delivery of PPI in research 785 
Key Findings Recommendations for improving  PPI in research 
 Best Practice 
A. Overall PPI in research was low  and inconsistent 
across research design and topics 
1. Promote PPI as a core research function in all research by raising awareness of its value and impact 
B. PPI was mostly limited to a few activities in the 
research cycle 
2. Identify and share good examples of PPI activity across the research cycle to improve range and quality of 
PPI in future funded projects 
3. Raise awareness of and promoting the role of PPI in the lowest areas of activity, where appropriate and 
justified 
C. ‘Best Practice’ was inconsistent 
 
4. Create dedicated champion(s) for PPI within research institutions to promote best practice  
5. Establish and implement a best practice framework to enable appropriate and meaningful PPI 
6. Stimulate sharing of best practice and resources for PPI across research organisations and institutions 
7. Improve the skills of researchers and member of the public for PPI  
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8. Establish a culture in which a) rewards and reimbursement of expenses are offered to PPI contributors as 
a matter of routine practice and b) PPI is appropriately costed in research 
9. Improve and support the recording and reporting of PPI 
10. Improve the accountability of public funded research to the general public 
D. Time to do PPI is the biggest consequence to 
researchers 
11. Raise awareness of time commitment for meaningful PPI so researchers can plan for it effectively 
E. PPI is good for research and researchers  12. Continue to showcase and celebrate the impact of PPI in research 
  
 SPCR Systems and Processes 
  
A. Overall PPI activity in 
research was low 
13. Increase the overall PPI activity in SPCR projects, by  developing networks for PPI groups and researchers, 
and encouraging sustainable processes and infrastructure for PPI 
 
B. PPI was mostly limited to a few activities in the 
research cycle 
14. Increase the range of appropriate PPI in SPCR funded research, by providing more guidance and support 
to researchers and grant reviewers 
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C. PPI is poorly recorded and reported 15. Improve the recording and reporting of PPI in SPCR to promote transparency, support diversity and 
enable the evaluation of impact by improving reporting form templates and better monitoring of PPI in  
SPCR activities and funded research 
 786 
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 787 
Table 6 Experience of lay co-applicants and co-authors (CR, AH) regarding their involvement in this study and 788 
its findings 789 
CR: “As a lay coordinator of a growing group of research users involved in a variety of primary care research 
projects across a clinical trials unit, I was very aware of the varied approaches to PPI being undertaken both 
regionally and nationally. So I was very interested in being involved in a project looking at PPI within a group 
of projects across one funder, looking particularly at the costs and benefits of PPI to the patients and the 
researchers, as not all costs are quantifiable and those that are, are not routinely recorded. Yet in my 
experience many patients and researchers go above and beyond what is asked of them, because they 
sincerely believe that patient involvement is an absolute must for good rigorous primary care research that 
can go on to be implemented to improve patients’ daily care. I was also keen to be involved in looking at the 
results and how they could be used to inform PPI practice for the future. 
However, it was disappointing that no opportunities for observations of meetings were forthcoming 
and quite worrying that no details of patients involved in the studies were available, so no real patient 
perspective could be obtained of what the costs and benefits to the patients were throughout the studies. 
So this highlights for me a gap in the literature where more research needs to be undertaken to fully 
understand the costs and benefits for the patients involved in primary care research. 
However I was impressed with the further specific recommendations on systems and processes 
compiled to fully integrate PPI into any future SPCR projects, which showed a real commitment from the 
SPCR to learn from the study findings.” 
 
AH: “I have enjoyed being a co-applicant on this study. I feel that I have been involved in all areas of the 
study.  I think that the study is essential as it shows the inconsistency of reporting PPI. 
I feel very disappointed about the response rate for the questionnaire, as no patient data was collected due 
to researchers being unwilling or unable to do this. This proves that there is a large gap here that needs to 
be addressed. I have also been surprised that in a lot of cases there were no plans for PPI, and for many 
researchers they held insufficient if any information. On the positive side - this paper will highlight areas for 
improvement and hopefully that will help to change attitudes and perspectives in the future.” 
 790 
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Figure 1 Evidence of PPI in SPCR funded project grant applications and annual/final reports by funding round 
(N=200) 
 
* Details of the respective funding rounds was unavailable for 18 projects 
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Figure 3 Consistency of PPI activities reported in annual/final reports compared to the plans for PPI within 
the project proposal (N=179) 
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Figure 4 Levels of best practice for PPI in SPCR projects, according to Boote et al's quality indicators [25] 
 
 
^ Combination of two quality indicators linked with expenses: travel costs and indirect costs (e.g. carer costs); 
* Combines three quality indicators: ‘contribution of PPI included in research reports and papers’, ‘PPI 
acknowledged in research reports and papers’ and ‘details of PPI reported in research reports and 
publications’. Data obtained from a PubMed search for articles associated with the 15 projects included in the 
analysis; # Adaptation of the quality indicator: ‘PPI offered mentors for personal and technical support’; $ 
Adaptation of the quality indicator: ‘Research findings were distributed to patients involved in the research in 
an appropriate format’ 
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Figure 5 Quality-Impact Index scores: The association between the Quality Score (number of quality indicators met by a 
project) and the Impact Score (number of PPI activities which the PI reported a perceived impact)  
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